| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |